rps4x Antibody

What is RPS4X and what cellular functions does it perform?

RPS4X is a component of the small (40S) ribosomal subunit responsible for protein synthesis in cells. It functions as part of the small subunit (SSU) processome, the first precursor of the small eukaryotic ribosomal subunit. During SSU processome assembly in the nucleolus, RPS4X works with other ribosome biogenesis factors to facilitate RNA folding, modifications, rearrangements, and cleavage . The ability of RPS4X to incorporate into the ribosome ensures efficient translation of genetic information from mRNA into corresponding polypeptide chains . This protein is primarily localized to the nucleus and cytoplasm and is widely expressed across many tissue types .

What are the key differences between RPS4X and its Y-linked homolog?

RPS4X (X-linked) and RPS4Y1 (Y-linked) are homologous proteins with approximately 93% sequence identity . Despite this high homology, they contain 19 amino acid differences distributed throughout their sequences . These differences make it challenging but possible to develop antibodies that specifically detect one variant without cross-reacting with the other. The Y-linked variant is only expressed in males, while the X-linked variant is expressed in both males and females, as confirmed through RT-PCR analysis of peripheral blood mononuclear cells .

What types of RPS4X antibodies are commercially available and what applications are they suitable for?

Both polyclonal and monoclonal antibodies against RPS4X are commercially available. Polyclonal antibodies like the rabbit polyclonal RPS4X/SCAR antibody (ab211427) are suitable for multiple applications including immunohistochemistry on paraffin-embedded tissues (IHC-P), Western blotting (WB), and immunocytochemistry/immunofluorescence (ICC/IF) . These antibodies can detect endogenous levels of RPS4X protein in human samples . Additionally, specific monoclonal antibodies have been developed that can distinguish between RPS4X and RPS4Y1, which is particularly important when studying gender-specific expression patterns .

How can RPS4X expression be accurately quantified in tissue samples?

For quantitative analysis of RPS4X expression in tissue samples, immunohistochemistry combined with integrated optical density (IOD) analysis is recommended. As demonstrated in studies on intrahepatic cholangiocarcinoma (ICC), tissue microarrays (TMAs) can be constructed using formalin-fixed paraffin-embedded tumor tissues. Using 4-μm-thick sections for IHC followed by IOD analysis provides a quantitative measure of RPS4X expression . When performing such analysis, it's crucial to include appropriate controls (such as inflamed bile duct tissues as demonstrated in ICC studies) and to standardize staining conditions across all samples .

What controls should be included when studying RPS4X expression patterns?

When studying RPS4X expression, several controls should be included:

• Tissue-specific controls: Include normal counterparts of the tissue being studied

• Negative controls: Slides omitting the primary antibody

• Gender-specific controls: When relevant, include male and female samples to account for RPS4X/RPS4Y expression differences

• Positive controls: Include tissues known to express RPS4X at detectable levels

• Isotype controls: Include appropriate isotype-matched immunoglobulins

In studies examining RPS4X as a biomarker in intrahepatic cholangiocarcinoma, inflammation of the bile duct tissues served as effective control samples for comparison .

How can I distinguish between RPS4X and RPS4Y1 in my experiments?

Distinguishing between RPS4X and RPS4Y1 requires careful antibody selection or molecular approaches. For antibody-based discrimination, use monoclonal antibodies specifically developed against unique epitopes in RPS4Y1. Researchers have successfully developed monoclonal antibodies targeting three small regions (designated Y1, Y2, Y3) with the highest concentration of amino acids specific to RPS4Y1 . The most effective epitope region for antibody production appears to be the 155-177 amino acid region of RPS4Y1 .

Alternatively, RT-PCR can be employed using primers designed to specifically amplify either RPS4X or RPS4Y1 transcripts. Studies have demonstrated successful amplification of a 196 bp product for RPS4X in both male and female samples, while a 167 bp product for RPS4Y1 is only amplified in male samples .

What is the significance of RPS4X in cancer research and how can it be studied as a biomarker?

RPS4X has emerged as a potential biomarker in cancer research, particularly in intrahepatic cholangiocarcinoma (ICC). Studies have shown that RPS4X is significantly upregulated in ICC tissues compared to inflamed bile duct tissues . To evaluate its diagnostic value, researchers have employed receiver operating characteristic (ROC) curve analysis, which yielded an area under the curve value of 0.9030 with 82.59% sensitivity and 100% specificity for detecting ICC .

How does RPS4X interact with the MDM2 protein and what are the implications for cancer research?

RPS4X has been identified as a novel binding partner of MDM2 (Mouse Double Minute 2 homolog), a key negative regulator of the tumor suppressor p53. This interaction occurs in the nucleoplasm, as demonstrated through co-immunoprecipitation and fluorescent protein localization studies . When expressed alone, RPS4X primarily localizes to the nucleolus, but when co-expressed with MDM2, it redistributes to the nucleoplasm where it co-localizes with MDM2 .

Structure-function studies using deletion mutants have revealed that the N-terminus of RPS4X binds to the central domain of MDM2 . This interaction promotes MDM2 stability, which could have significant implications for p53 regulation and cancer development.

To study these interactions, researchers can employ:

• Co-immunoprecipitation assays with anti-RPS4X antibodies

• Fluorescent protein tagging (such as mCherry-RPS4X and GFP-MDM2) for localization studies

• Deletion mutant constructs to map specific interaction domains

• Yeast two-hybrid systems for initial screening of protein interactions

What role does RPS4X play in ribosomal biogenesis beyond protein translation?

Beyond its role in protein translation, RPS4X participates in the small subunit (SSU) processome, which is the first precursor of the small eukaryotic ribosomal subunit . During SSU processome assembly in the nucleolus, RPS4X works collaboratively with many ribosome biogenesis factors, RNA chaperones, and other ribosomal proteins to facilitate critical processes including:

• RNA folding and structural rearrangements

• Chemical modifications of pre-rRNA

• Cleavage events in pre-ribosomal RNA

• Targeted degradation of pre-ribosomal RNA by the RNA exosome

To study these processes, researchers can employ RNA-protein interaction assays, nucleolar isolation techniques, and ribosome profiling approaches. Antibodies against RPS4X are valuable tools for tracking its incorporation into pre-ribosomal complexes during various stages of ribosome biogenesis.

What are the optimal conditions for detecting RPS4X using Western blotting?

For optimal detection of RPS4X using Western blotting, consider the following protocol recommendations:

• Sample preparation: Use standard cell lysis buffers supplemented with protease inhibitors

• Protein loading: 10-20 μg of total protein per lane is typically sufficient

• Gel separation: 12-15% SDS-PAGE gels provide optimal separation for this ~30 kDa protein

• Transfer conditions: Use PVDF or nitrocellulose membranes with standard transfer buffers

• Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Primary antibody: Dilute RPS4X antibody according to manufacturer recommendations (typically 1:1000 to 1:2000) and incubate overnight at 4°C

• Secondary antibody: HRP-conjugated anti-rabbit IgG (for rabbit polyclonal antibodies) at 1:5000 dilution

• Detection: Enhanced chemiluminescence (ECL) systems are suitable for visualization

Expected results include a band at approximately 30 kDa corresponding to RPS4X. When using antibodies that may cross-react with RPS4Y1, consider including male and female samples as controls to help distinguish between these homologous proteins.

Why might I observe cross-reactivity between RPS4X and RPS4Y1, and how can this be minimized?

Cross-reactivity between RPS4X and RPS4Y1 occurs due to their high sequence homology (approximately 93%) . To minimize this issue:

• Select antibodies that target regions with the greatest amino acid differences between the two proteins

• Use monoclonal antibodies specifically developed against unique epitopes (such as those targeting the 155-177 amino acid region of RPS4Y1)

• Validate antibody specificity using samples from both males (expressing both RPS4X and RPS4Y1) and females (expressing only RPS4X)

• Consider molecular approaches like RT-PCR with isoform-specific primers as complementary methods

• For critical applications, perform immunodepletion experiments with one isoform to confirm specificity for the other

When designing or selecting antibodies, focus on the 19 amino acid differences distributed throughout the sequence, with particular attention to three regions (designated Y1, Y2, Y3) that contain the highest concentration of RPS4Y1-specific amino acids .

What sample preparation techniques are recommended for immunohistochemical detection of RPS4X?

For optimal immunohistochemical detection of RPS4X in tissue samples:

• Fixation: Fix tissues in 10% neutral buffered formalin at room temperature for 12-24 hours

• Embedding: Process and embed in paraffin using standard protocols

• Sectioning: Prepare 4-μm-thick sections on positively charged slides

• Antigen retrieval: Perform heat-induced epitope retrieval in citrate buffer (pH 6.0) or as recommended for your specific antibody

• Blocking: Block endogenous peroxidase activity with hydrogen peroxide and non-specific binding with appropriate serum

• Primary antibody: Incubate with anti-RPS4X antibody at optimized dilution (e.g., 1:200) for 1-2 hours at room temperature or overnight at 4°C

• Detection system: Use detection systems like EnVision™ with diaminobenzidine (DAB) chromogen

• Counterstaining: Lightly counterstain with hematoxylin

• Controls: Include sections without primary antibody as negative controls

This protocol has been successfully employed in studies examining RPS4X expression in intrahepatic cholangiocarcinoma tissues .

How can discrepancies between RPS4X protein levels and mRNA expression be investigated?

Discrepancies between RPS4X protein levels and mRNA expression can arise from various post-transcriptional regulatory mechanisms. To investigate these discrepancies:

• Confirm antibody specificity using positive and negative controls

• Verify both protein and mRNA detection methods using samples with known expression profiles

• Assess protein stability through cycloheximide chase experiments

• Investigate potential post-translational modifications using phospho-specific antibodies or mass spectrometry

• Examine the impact of microRNAs that might regulate RPS4X translation

• Consider the effects of protein-protein interactions (such as with MDM2) that might affect protein stability

• Analyze polysome profiles to assess translational efficiency of RPS4X mRNA

When interpreting contradictory results, remember that RPS4X functions in different cellular compartments and its localization can change depending on interactions with other proteins, as demonstrated in studies of its interaction with MDM2 .

How can RPS4X be studied in the context of gender-specific biology?

The existence of both X-linked (RPS4X) and Y-linked (RPS4Y1) forms of the S4 ribosomal protein offers unique opportunities for studying gender-specific biology. To investigate this aspect:

• Compare translation efficiency and ribosomal function in male versus female cells

• Develop cell models with selective knockdown of either RPS4X or RPS4Y1

• Utilize the specific monoclonal antibodies that can distinguish between RPS4X and RPS4Y1 proteins

• Perform comparative proteomics to identify differences in proteins synthesized in the presence of either RPS4X or RPS4Y1

• Investigate potential compensatory mechanisms in males versus females

The development of specific monoclonal antibodies against RPS4Y1 that can detect male-specific protein expression in mixed cell populations provides a valuable tool for such studies .

What techniques can be used to study the role of RPS4X in cancer drug resistance?

Given the association of RPS4X with cisplatin resistance in bladder and ovarian cancer , several approaches can be employed to study its role in drug resistance:

• Expression modulation: Use siRNA/shRNA for knockdown or overexpression vectors to manipulate RPS4X levels

• Drug sensitivity assays: Compare IC50 values for various chemotherapeutics in cells with different RPS4X expression levels

• Patient-derived xenografts: Evaluate correlation between RPS4X expression and treatment response

• Clinical sample analysis: Perform retrospective studies correlating RPS4X expression with treatment outcomes

• Protein interaction studies: Investigate how RPS4X interacts with known drug resistance mediators

• Combination therapy testing: Assess whether targeting RPS4X could sensitize resistant cells to standard chemotherapies

For comprehensive analysis, both in vitro and in vivo models should be employed, along with validation in clinical samples as demonstrated in studies of intrahepatic cholangiocarcinoma .

How does the interaction between RPS4X and MDM2 impact p53 signaling pathways?

The discovery that RPS4X interacts with MDM2 and promotes its stability opens important questions about p53 regulation. To investigate this relationship:

• Assess p53 levels and activity in cells with modulated RPS4X expression

• Determine whether RPS4X affects MDM2-mediated p53 ubiquitination and degradation

• Evaluate the impact of cellular stress (DNA damage, ribosomal stress) on the RPS4X-MDM2 interaction

• Investigate whether RPS4X competes with p53 for binding to MDM2

• Examine potential changes in p53 target gene expression in response to altered RPS4X levels

• Study how the subcellular redistribution of RPS4X (from nucleolus to nucleoplasm) upon MDM2 binding affects ribosome biogenesis

These investigations would build upon the current understanding that the N-terminus of RPS4X binds to the central domain of MDM2 in the nucleoplasm , providing insights into how ribosomal proteins participate in cellular stress responses and cancer development.